Health · 21 views
Key FDA committee unanimously recommends its first vaccine since 2023
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 21 Community interest
Brief read Under 1 min brief 34 words
AI Summary
A key FDA committee has made a unanimous decision regarding a new vaccine. All nine members of the committee voted in favor of recommending Moderna's mRNA influenza vaccine for adults aged 50 and over.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Australian pollen season may be arriving early in eastern statesContinue reading
- An administrative gap delays access to new pancreatic cancer treatmentContinue reading
- The key to successful treatment of primary aldosteronism: Get it earlyContinue reading
- Children with cancer are being saved, but are we breaking them in the process?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow